logo

6.04

6.04 (-0.40%)

As of Mar 06, 2024

Pds Biotechnology Corp [PDSB]

Source: 

Company Overview

Pds Biotechnology Corp is a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer and infectious disease immunotherapies based on our proprietary Versamune  , Versamune plus IL-12 and Infectimune™ T cell activating technology platforms.

CountryUnited States
Headquartersflorham parknew jersey
Phone Number800-208-3343
Industry
manufacturing
CEOFrank Bedu-Addo
Websitewww.pdsbiotech.com